Your browser doesn't support javascript.
loading
Risk factors for serious infections and infection-related mortality in patients with microscopic polyangiitis: Multicentre REVEAL cohort study.
Manabe, Atsushi; Kadoba, Keiichiro; Hiwa, Ryosuke; Kotani, Takuya; Shoji, Mikihito; Shirakashi, Mirei; Tsuji, Hideaki; Kitagori, Koji; Akizuki, Shuji; Nakashima, Ran; Yoshifuji, Hajime; Yamamoto, Wataru; Okazaki, Ayana; Matsuda, Shogo; Gon, Takaho; Watanabe, Ryu; Hashimoto, Motomu; Morinobu, Akio.
Afiliação
  • Manabe A; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kadoba K; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Hiwa R; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kotani T; Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Shoji M; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Shirakashi M; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Tsuji H; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kitagori K; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Akizuki S; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Nakashima R; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yoshifuji H; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yamamoto W; Department of Health Information Management, Kurashiki Sweet Hospital, Okayama, Japan.
  • Okazaki A; Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Matsuda S; Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Gon T; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Watanabe R; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Hashimoto M; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Morinobu A; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Mod Rheumatol ; 2024 Mar 29.
Article em En | MEDLINE | ID: mdl-38564330
ABSTRACT

OBJECTIVE:

Infections are a critical concern for patients with microscopic polyangiitis (MPA). This study aimed to identify the risk factors associated with serious infections (SIs) and infection-related mortality in patients with MPA, as well as the effect of glucocorticoid (GC) dose tapering on these outcomes.

METHODS:

This multicentre, retrospective, and observational study utilised data from a cohort of patients with MPA in Japan [Registry of Vasculitis Patients to Establish REAL World Evidence (REVEAL) cohort]. Patients were categorised based on the occurrence of SIs or infection-related deaths, and various characteristics were compared among the groups.

RESULTS:

Among 182 patients, 66 (36.2%) experienced 129 SIs and 27 (14.8%) developed infection-related deaths. Advanced age, elevated C-reactive protein (CRP) levels, and higher ratio of the GC dose at 3 months to the initial dose were identified as independent risk factors for SIs. Older age was also associated with infection-related deaths. Furthermore, the cumulative incidence of infection-related deaths was significantly higher in patients with a higher ratio of the GC dose at 24 months to the initial dose.

CONCLUSION:

Older age, elevated CRP levels, and slower GC dose tapering predispose patients to SIs and infection-related deaths. Strategies, such as rapid GC dose tapering, are anticipated to mitigate the risk of infections.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article